Literature DB >> 12055990

Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications.

Philip W Gold1, K Eddie Gabry, Mariko R Yasuda, George P Chrousos.   

Abstract

Mediators of neuroendocrine and autonomic function seem to play important roles in the core symptoms of major depression. Although centrally directed corticotropin-releasing hormones and norepinephrine contribute to core symptoms such as alterations in anxiety, arousal, and mood, they also exert significant potentially clinically relevant effects on key processes that proceed in the periphery. Thus, the core clinical manifestations of major depression may represent a fraction of a complicated systemic illness that not only influences thought and feeling, but also the processes involved in premature cardiovascular disease, osteoporosis, and premature death. Subdividing patients with major depression into meaningful biologic subgroups will facilitate the elucidation of the mechanisms that underlie the central and peripheral manifestations of major depressive illness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055990     DOI: 10.1016/s0889-8529(01)00022-6

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  32 in total

Review 1.  Stress and disorders of the stress system.

Authors:  George P Chrousos
Journal:  Nat Rev Endocrinol       Date:  2009-06-02       Impact factor: 43.330

2.  Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

Authors:  C Heesen; L Nawrath; C Reich; N Bauer; K-H Schulz; S M Gold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 3.  Are BDNF and glucocorticoid activities calibrated?

Authors:  F Jeanneteau; M V Chao
Journal:  Neuroscience       Date:  2012-09-26       Impact factor: 3.590

Review 4.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

Review 5.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

6.  BDNF Val66Met polymorphism and stressful life events in melancholic childhood-onset depression.

Authors:  Timea Rimay; Istvan Benak; Eniko Kiss; Ildiko Baji; Agnes Feher; Anna Juhasz; John Strauss; James Kennedy; Cathy Barr; Maria Kovacs; Agnes Vetro; Krisztina Kapornai
Journal:  Psychiatr Genet       Date:  2015-12       Impact factor: 2.458

7.  Association between maternal mood and oxytocin response to breastfeeding.

Authors:  Alison M Stuebe; Karen Grewen; Samantha Meltzer-Brody
Journal:  J Womens Health (Larchmt)       Date:  2013-04       Impact factor: 2.681

Review 8.  Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter.

Authors:  Alexander Neumeister; Theresa Young; Juergen Stastny
Journal:  Psychopharmacology (Berl)       Date:  2004-07-13       Impact factor: 4.530

9.  Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study.

Authors:  Rebecca L Ross; Kim D Jones; Rachel L Ward; Lisa J Wood; Robert M Bennett
Journal:  BMC Musculoskelet Disord       Date:  2010-06-14       Impact factor: 2.362

10.  Behavior and pro-inflammatory cytokine variations among submissive and dominant mice engaged in aggressive encounters: moderation by corticosterone reactivity.

Authors:  Marie-Claude Audet; Emily N Mangano; Hymie Anisman
Journal:  Front Behav Neurosci       Date:  2010-08-23       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.